Various health-related effects of long-chain (LC) ω-3 PUFAs, EPA, and DHA have been
suggested. LC ω-3 PUFAs reduce TG concentrations and have anti-inflammatory …

The recent publication of the REDUCE-IT study has reopened the debate about the efficacy
of omega-3 fatty acids in reducing the risk of cardiovascular (CV) events. This meta-analysis …

Abstract The 2015 Dietary Guidelines for Americans recommend limiting the intake of
saturated fatty acids (SFAs) to< 10% of energy/d and replacing dietary SFAs with …

Omega-3 polyunsaturated fatty acid (ω-3 PUFA) therapy continues to show great promise in
primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most …

Considerable research supports cardiovascular benefits of consuming omega-3 PUFA, also
known as (n-3) PUFA, from fish or fish oil. Whether individual long-chain (n-3) PUFA have …

Today, there are several observational and experimental studies, especially clinical
randomized trials, that have proven the beneficial effects of n-3 polyunsaturated fatty acids …

We reviewed available evidence for cardiovascular effects of n-3 polyunsaturated fatty acid
(PUFA) consumption, focusing on long chain (seafood) n-3 PUFA, including their principal …

Lower incidence of cardiovascular disease (CVD) in the Greenland Inuit, Northern Canada
and Japan has been attributed to their consumption of seafood rich in long chain omega-3 …

This paper reviews the current evidence regarding long‐chained marine omega‐3
polyunsaturated fatty acids (PUFAs) and cardiovascular disease (CVD), their possible …

Introduction: An epidemiological study of Greenlandic Inuit suggested the importance of
omega-3 polyunsaturated fatty acids (PUFAs) in preventing ischemic heart disease. After …